Heterogeneity in response to interleukin 2 and interleukin 2-producing ability of adult T cell leukemic cells. 1987

N Arima, and Y Daitoku, and Y Yamamoto, and K Fujimoto, and S Ohgaki, and K Kojima, and J Fukumori, and K Matsushita, and H Tanaka, and K Onoue

To examine the possibility of heterogeneous mechanisms in the proliferation of adult T cell leukemia (ATL) cells, leukemic cells from 13 patients, nine acute-type and four chronic-type ATL, were examined for the production of interleukin 2 (IL 2) with or without mitogenic stimulation and their response to recombinant IL 2 when exogeneously added. The leukemic cells were classified into four groups, as follows. Group 1 (two patients): Cells of this group produced IL 2 messenger RNA, secreted IL 2, and proliferated when cultured in mitogen-free medium. The spontaneous proliferation of the cells in mitogen-free medium was inhibited by anti-Tac/IL 2 receptor and anti-IL 2 monoclonal antibodies. Moreover, the thymidine incorporation by the cells was enhanced in response to exogeneously added recombinant IL 2 and IL 2 produced by themselves. These results indicate that the ATL cells of this group proliferate with autostimulation by IL 2. Group 2 (seven patients): Cells of this group did not secrete IL 2 when cultured in mitogen-free medium, but the cells showed response to exogeneously added recombinant IL 2 and proliferated in culture. These results indicate that the ATL cells of this group proliferate by a paracrine mechanism. Group 3 (one patient): Cells of this group secreted IL 2 in mitogen-free medium. However, the spontaneous proliferation of these cells in vitro was very low, and the response to recombinant IL 2 was also very low. Group 4 (three patients): Cells of this group did not secrete IL 2 in mitogen-free medium. Spontaneous proliferation and the response to recombinant IL 2 were also very low. The clinical feature of all patients of Groups 1 and 2 was acute-type, and that of Groups 3 and 4 was chronic-type. Thus, we conclude that heterogeneous mechanisms exist in the proliferation of leukemic cells, and that growth rate in mitogen-free medium and response to IL 2 of the cells may have a significant relationship to the clinical feature, acute- or chronic-type.

UI MeSH Term Description Entries
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008934 Mitogens Substances that stimulate mitosis and lymphocyte transformation. They include not only substances associated with LECTINS, but also substances from streptococci (associated with streptolysin S) and from strains of alpha-toxin-producing staphylococci. (Stedman, 25th ed) Mitogen,Phytomitogen,Phytomitogens
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D005260 Female Females
D006800 Deltaretrovirus Infections Infections caused by the HTLV or BLV deltaretroviruses. They include human T-cell leukemia-lymphoma (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED). BLV Infections,HTLV Infections,HTLV-BLV Infections,BLV Infection,Deltaretrovirus Infection,HTLV BLV Infections,HTLV Infection,HTLV-BLV Infection,Infection, Deltaretrovirus,Infections, Deltaretrovirus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

N Arima, and Y Daitoku, and Y Yamamoto, and K Fujimoto, and S Ohgaki, and K Kojima, and J Fukumori, and K Matsushita, and H Tanaka, and K Onoue
October 1988, Blood,
N Arima, and Y Daitoku, and Y Yamamoto, and K Fujimoto, and S Ohgaki, and K Kojima, and J Fukumori, and K Matsushita, and H Tanaka, and K Onoue
April 1996, Blood,
N Arima, and Y Daitoku, and Y Yamamoto, and K Fujimoto, and S Ohgaki, and K Kojima, and J Fukumori, and K Matsushita, and H Tanaka, and K Onoue
September 1990, Japanese journal of cancer research : Gann,
N Arima, and Y Daitoku, and Y Yamamoto, and K Fujimoto, and S Ohgaki, and K Kojima, and J Fukumori, and K Matsushita, and H Tanaka, and K Onoue
August 1986, European journal of immunology,
N Arima, and Y Daitoku, and Y Yamamoto, and K Fujimoto, and S Ohgaki, and K Kojima, and J Fukumori, and K Matsushita, and H Tanaka, and K Onoue
October 1992, Leukemia,
N Arima, and Y Daitoku, and Y Yamamoto, and K Fujimoto, and S Ohgaki, and K Kojima, and J Fukumori, and K Matsushita, and H Tanaka, and K Onoue
January 1986, Leukemia research,
N Arima, and Y Daitoku, and Y Yamamoto, and K Fujimoto, and S Ohgaki, and K Kojima, and J Fukumori, and K Matsushita, and H Tanaka, and K Onoue
April 1988, The Journal of experimental medicine,
N Arima, and Y Daitoku, and Y Yamamoto, and K Fujimoto, and S Ohgaki, and K Kojima, and J Fukumori, and K Matsushita, and H Tanaka, and K Onoue
April 1993, Japanese journal of cancer research : Gann,
N Arima, and Y Daitoku, and Y Yamamoto, and K Fujimoto, and S Ohgaki, and K Kojima, and J Fukumori, and K Matsushita, and H Tanaka, and K Onoue
February 1986, Blood,
N Arima, and Y Daitoku, and Y Yamamoto, and K Fujimoto, and S Ohgaki, and K Kojima, and J Fukumori, and K Matsushita, and H Tanaka, and K Onoue
January 1993, Folia biologica,
Copied contents to your clipboard!